ETRA

Electra Therapeutics, Inc.

Healthcare · Biotechnology

$190.36 sample

-1.12 (-0.58%) 1D

Market cap

$869.3B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-16

Alerts

8

Price$190.36 +4.22% 3M daily closessample

193.27175.94

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 24INSInsider sell: Director
Sep 16SECDEF 14A filed
Sep 07SECDEF 14A filed
Aug 27INSInsider sell: Director
Aug 18INSInsider buy: Director
Aug 11SECForm 144 filed
Aug 06INSInsider sell: Chief Financial Officer
Jul 28INSInsider sell: Chief Executive Officer

Sign up to see the real ETRA record →

Company facts

SEC EDGAR registration

Name: Electra Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -39sample, -100 to +100
Reporting currency: USD

Who is positioning in ETRA

sample

Insiders: 19 insider transactions over 90 days, net selling, $512.5M
Congress: 2 members traded over 90 days
Institutions · 13F: 41 funds hold $17.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$35.5B +20.6% y/y

Q4 2024Q3 2026

Inventory$21.6B +14.4% y/y

Q4 2024Q3 2026

Accounts receivable$16.0B +17.3% y/y

Q4 2024Q3 2026

Total debt$42.4B +15.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $569.2B +13.8% 3M
Sample peer B: $406.0B +9.8% 3M
Sample peer C: $435.9B -12.0% 3M
Sample peer D: $852.0B -8.2% 3M
Sample peer E: $773.6B -13.5% 3M